Ledger.Open graph →
SEC Form D · filed November 21, 2016

MBF Therapeutics, Inc

Offering
$1.1M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AMBLER, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Christopher M. Cashman · Ambler, PADirectorThomas Tillett · Ambler, PAExec · DirectorSherwin D. Jannat · New York, NYDirectorJohn D. Rutledge · New York, NYExec · DirectorRakesh Narasimhan · Seattle, WADirectorMarian Joh · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗